Druggable targets, clinical trial design and proposed pharmacological management in fibrodysplasia ossificans progressiva-Reference-Cited by-同舟云学术

Druggable targets, clinical trial design and proposed pharmacological management in fibrodysplasia ossificans progressiva

Published:2020-04-02 Issue:4 Volume:8 Page:101-109
ISSN:2167-8707
Container-title:Expert Opinion on Orphan Drugs
language:en
Short-container-title:Expert Opinion on Orphan Drugs

Author:

Pignolo Robert J.¹,Kaplan Frederick S.²

Affiliation:

1. Departments of Medicine, Physiology & Biomedical Engineering, and the Robert and Arlene Kogod Center on Aging, Alix School of Medicine, Mayo Clinic, Rochester, MN, USA

2. Departments of Orthopaedic Surgery, Medicine, and the Center for Research in FOP & Related Disorders, The Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/21678707.2020.1751122

Reference59 articles.

1. Fibrodysplasia Ossificans Progressiva: Clinical and Genetic Aspects

2. Fibrodysplasia Ossificans Progressiva (FOP): A Segmental Progeroid Syndrome

3. Clinical Utility Gene Card for: Fibrodysplasia ossificans progressiva

4. Clinical-pathological correlations in three patients with fibrodysplasia ossificans progressiva

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell Senescence in Heterotopic Ossification;Biomolecules;2024-04-16

2. Matrix metalloproteinase-9 deficiency confers resilience in fibrodysplasia ossificans progressiva in a man and mice;Journal of Bone and Mineral Research;2024-02-16

3. Navigating the Complex Landscape of Fibrodysplasia Ossificans Progressiva: From Current Paradigms to Therapeutic Frontiers;Genes;2023-11-30

4. Multi-omics therapeutic perspective on ACVR1 gene: from genetic alterations to potential targeting;Briefings in Functional Genomics;2022-08-25

5. Current challenges and opportunities in the care of patients with fibrodysplasia ossificans progressiva (FOP): an international, multi-stakeholder perspective;Orphanet Journal of Rare Diseases;2022-04-18